Chemotherapy of malignant hemangiopericytoma
- 1 April 1978
- Vol. 41 (4) , 1256-1260
- https://doi.org/10.1002/1097-0142(197804)41:4<1256::aid-cncr2820410406>3.0.co;2-v
Abstract
Thirty-nine chemotherapy trials in 16 patients with metastatic hemangiopericytoma treated at MSKCC and 33 trials from the literature are reviewed. Adriamycin, alone or in combination drug regimens, is the most effective agent, producing complete and partial remissions in 50% of cases. Other drugs which show some activity include vincristine, cyclophosphamide, actinomycin, methotrexate and DTIC. The available data indicate malignant hemangiopericytoma should be considered chemotherapeutically responsive tumors.This publication has 17 references indexed in Scilit:
- HemangiopericytomaHuman Pathology, 1976
- Continuous intravenous infusions of 5-fluoro-2′-deoxyuridine in the treatment of solid tumorsCancer, 1973
- Clinical Trials with Adriamycin. Results of Three-Years StudyPublished by Springer Nature ,1972
- Blood Levels, Tissue Distribution and Clinical Effects of AdriamycinPublished by Springer Nature ,1972
- Combination Chemotherapy in the Treatment of Metastatic HemangiopericytomaOncology, 1972
- Clinical Evaluation of 5-(3,3-Dimethyl-1-Triazeno) Imidazole-4-Carboxamide in Malignant Melanoma and Other Neoplasms: Comparison of Twice-weekly and Daily Administration SchedulesOncology, 1971
- Hemangiopericytoma.Report of a case and comprehensive review of the literatureCancer, 1970
- Treatment of pulmonary metastatic disease with radiation therapy and adjuvant actinomycin D.Preliminary observationsCancer, 1969
- Metastatic hemangiopericytoma treated with vincristine and actinomycin DCancer, 1969
- Irradiation of Hemangiopericytoma of StoutRadiology, 1960